Expeditors (EXPD) Form 4: CFO Powell records routine DER accrual
Rhea-AI Filing Summary
Form 4 overview – Expeditors International of Washington (EXPD)
On 16 Jun 2025, Senior VP & CFO Bradley S. Powell reported routine acquisitions of dividend-equivalent rights (DERs) that accrue on previously granted restricted stock units (RSUs). No common shares were bought or sold; the filing simply records automatic adjustments triggered by the company’s quarterly cash dividend.
- 2023 RSU grant: 11.793 DERs acquired; post-transaction balance 52.760.
- 2024 RSU grant: 22.983 DERs acquired; post-transaction balance 64.760.
- 2025 RSU grant: 36.844 DERs acquired; post-transaction balance 36.844.
The reference price disclosed for the DERs is $115.11 per share, matching the dividend calculation basis. Following the accruals, Powell directly owns 12,340.0367 EXPD common shares and the derivative balances listed above. Ownership remains direct; no dispositions occurred and no Rule 10b5-1 trading plan box was checked. The activity is administrative in nature and does not alter the executive’s economic exposure to EXPD common stock.
Positive
- None.
Negative
- None.
Insights
TL;DR CFO accrued 71.62 dividend rights; no share sales; neutral for investors.
The filing reflects non-cash accruals tied to cash dividends on existing RSUs. Because DERs vest concurrently with the underlying RSUs, the economic impact is minimal and fully anticipated. The CFO’s direct share count stays constant at 12,340.0367, signalling continued alignment but offering no incremental insight into management’s outlook. With no purchases, sales, or option exercises, the disclosure is operationally routine and should not influence valuation models or liquidity assumptions.
TL;DR Routine DER accrual; no governance red flags or strategic signals.
Dividend-equivalent accruals are standard practice to keep RSU holders economically whole when cash dividends are paid. The absence of dispositions or hedging activity suggests no deviation from EXPD’s insider-trading policy. All shares remain under direct ownership, which preserves transparency of beneficial interest. Consequently, the filing is administrative and carries no material governance implications.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Dividend Equivalent Rights - 2023 RSUs | 11.793 | $115.11 | $1K |
| Grant/Award | Dividend Equivalent Rights - 2024 RSUs | 22.983 | $115.11 | $3K |
| Grant/Award | Dividend Equivalent Rights - 2025 RSUs | 36.844 | $115.11 | $4K |
| holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2023 grant of restricted stock units and vest proportionately with the restricted stock units to which they relate.
- F2. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2024 grant of restricted stock units and vest proportionately with the restricted stock units to which they relate.
- F3. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2025 grant of restricted stock units and vest proportionately with the restricted stock units to which they relate.
AI-generated analysis. How Rhea-AI works. Not financial advice.